U.S. markets open in 7 hours 2 minutes
  • S&P Futures

    +9.75 (+0.24%)
  • Dow Futures

    +97.00 (+0.30%)
  • Nasdaq Futures

    +26.50 (+0.21%)
  • Russell 2000 Futures

    +7.20 (+0.41%)
  • Crude Oil

    +0.12 (+0.16%)
  • Gold

    +2.60 (+0.13%)
  • Silver

    +0.01 (+0.06%)

    +0.0016 (+0.15%)
  • 10-Yr Bond

    0.0000 (0.00%)
  • Vix

    -1.14 (-5.24%)

    +0.0038 (+0.31%)

    -0.6360 (-0.48%)
  • Bitcoin USD

    -662.54 (-2.39%)
  • CMC Crypto 200

    -17.86 (-2.94%)
  • FTSE 100

    +66.32 (+0.90%)
  • Nikkei 225

    +41.38 (+0.15%)

Breast Reconstruction Market Size to Reach USD 826.2 Million in 2030 | Emergen Research

VANCOUVER, BC, Feb. 2, 2023 /PRNewswire/ -- The breast reconstruction market size reached USD 464.8 Million in 2021 and is expected to register a CAGR of 6.5% during the forecast period, according to latest analysis by Emergen Research. Increasing incidence of breast cancer and improving reimbursements for breast reconstruction procedures are the primary factors driving revenue growth of global breast reconstruction market.


According to the GLOBOCAN 2020 report, breast cancer has now surpassed lung cancer as the most often diagnosed form of the disease worldwide. According to the World Health Organization, around 2.3 million women worldwide were diagnosed with breast cancer in 2020. Breast cancer was especially common among Asian women in 2020, making up 22.9% of all female cancer diagnoses. Increasing knowledge regarding the safety of breast reconstruction alternatives encourages people suffering from mastectomy and other breast cancer procedures to choose reconstruction.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1472


An increasing number of countries are covering the costs of breast reconstruction procedures, which has contributed to a surge in such procedures. Average reimbursement rate for pedicled flaps was USD 5,993.16, whereas the same for free flaps was USD 4,325.84. Another report found that breast reconstruction costs in Europe were reimbursed similarly across countries. Similarly, Medicare pays for breast reconstruction after a mastectomy for cancer provided the patient meets certain criteria. Services Australia reports that external breast prosthesis reimbursements scheme could cover the cost of the device for women who have had breast cancer.

For instance, The Australian government reimburses up to USD 400 for each replacement or new external breast prosthesis for breast cancer patients who have undergone breast surgery. Every two years from the date of the most recent prosthesis purchase, one can submit a claim for reimbursement. This deadline applies irrespective of the amount of the most recent reimbursement. These factors are driving revenue growth during the forecast period.


One of the major restraints of breast reconstruction industry is the presence of viable alternatives, particularly non-surgical procedures. In addition, the failure of a product owing to a defect is an additional significant factor in constraining growth. There have been several product recalls over the years due to defects or other problems.

For instance, on 30 December 2021, The FDA announced that it had ordered Allergan recall its BIOCELL textured breast implants due to the risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). The recall also includes various breast implants manufactured by BIOCELL, such as Natrelle Inspira silicone-filled breast implants, Natrelle silicone-filled breast implants, Natrelle saline-filled breast implants, and Natrelle 410 highly cohesive anatomically shaped silicone-filled breast implants.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1472

Growth Projections:

The breast reconstruction market is expected to register a CAGR of 6.5% over the forecast period and revenue is projected to increase from USD 464.8 Million in 2021 to USD 826.2 Million in 2030. Increasing awareness regarding breast reconstruction treatment is expected to support revenue growth of the market.

Current Trends and Innovations:

One technical innovation in cancer treatment is breast tomosynthesis, often known as 3-D mammography. This method utilizes images captured from all sides to render a breast in what appears to be three dimensions. The development of innovative mammography products by a number of market-leading businesses is driving the expansion of this industry. On May 18, 2022, Therapixel, a pioneer in the field of artificial intelligence (AI) software for women's health, announced the introduction of MammoScreen 2.0, a 2D and 3D version that can incorporate previously acquired mammograms into its analysis.

By comparing a mammogram to others, MammoScreen is able to perform better. The deep learning algorithm created by Therapixel can acquire new knowledge from existing visual data. The new MammoScreen can detect and categorize soft tissue lesions and worrisome calcifications in mammography and tomosynthesis pictures automatically.

Strategic Initiatives:

Major companies included in the market report Mentor Worldwide LLC, AbbVie, Sientra, Inc, POLYTECH Health & Aesthetics GmbH, GC Aesthetics, Sebbin, Establishment Labs S.A., integra LifeSciences, RTI Surgical, Ideal Implant Incorporated.

  • On 17 May 2022, GC Aesthetics, Inc. (GCA), a privately held medical technology business that offers Healthcare Aesthetic Solutions, launched the debut of FixNip NRI, an Advanced Nipple Areola Complex (NAC) Reconstruction Implant.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/breast-reconstruction-market

Scope of Research

Report Details


Market Size in 2021

USD 464.8 Million

CAGR (2022–2030)

6.5 %

Revenue Forecast to 2030

USD 826.2 Million

Base Year for Estimation


Historical Data


Forecast Period


Quantitative Units

Revenue in USD Million and CAGR in % from 2022 to 2030

Report Coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments Covered

Product, procedure, by type, end-use, and region

Regional Scope

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Country Scope

U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, and Rest of Middle East & Africa

Key Companies Profiled

Mentor Worldwide LLC., AbbVie, Sientra, Inc., POLYTECH Health & Aesthetics GmbH, GC Aesthetics, Sebbin, Establishment Labs S.A., Integra LifeSciences, RTI Surgical, and IDEAL IMPLANT INCORPORATED.

Customization Scope

10 hours of free customization and expert consultation

Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/1472

Emergen Research has segmented breast reconstruction market on the basis of product, procedure, type, end-use, and region:

  • Product Outlook (Revenue, USD Million; 2019-2030)

  • Procedure Outlook (Revenue, USD Million; 2019-2030)

  • Type Outlook (Revenue, USD Million; 2019-2030)

  • End-use Outlook (Revenue, USD Million; 2019-2030)

  • Regional Outlook (Revenue, USD Billion, 2019 - 2030)

Latest Research Reports Published by Emergen Research:

Network Engineering Services Market, By Service Type (Network Assessment and Network Deployment), By Organization Size (Small & Medium Enterprises and Large Enterprises) and By End-Use (BFSI Telecom and Healthcare), By Region Forecast to 2030

Operational Technology Market, By Component (Field Instruments and Control System), By Networking Technology (Wired, and Wireless), By Industry (Process Industry, Discrete Industry, and Others), and By Region Forecast to 2030

Medical Devices Batteries Market, by Product Type (Implantable and Non-Implantable Batteries), by Battery Type, by End User, and By Region Forecast to 2030

Clustered Regularly Interspaced Short Palindromic Repeats Technology Devices Market, By Product & Service (Kits & Enzymes, Libraries, Cell Line Engineering, and gRNA Design), By Application(Biomedical and Agricultural), By End-Use, and By Region Forecast to 2030

Pediatric Oncology Market, By Indication (Leukemia and Neuroblastoma), By Treatment (Chemotherapy and Radiotherapy), By End-Use (Hospitals and Cancer & Radiation Therapy Centers), and By Region Forecast to 2030

Cardiogenic Shock Market, By Treatment Type (Drugs, Devices, and In-Vitro Test Kits), By End-Use (Hospitals, Ambulatory Surgical Centers, and Others), and By Region Forecast to 2030

Subscriber Identity Module Cards Market, By Type, By Application (Mobile Phone, Tablet, Wearable Device, and Others), By SIM Memory, and By Region Forecast to 2030

Smoke Detector Market By Power Source (Battery-powered and Hardwired), By Product Type (Photoelectric Smoke Detectors, Ionization Smoke Detectors, and Others), By Service, By End-use, and By Region Forecast to 2030

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read our Press Release @ https://www.emergenresearch.com/press-release/global-breast-reconstruction-market
Trending Titles LiDAR Market | Metaverse Market

Logo: https://mma.prnewswire.com/media/1579538/Emergen_Research_Logo.jpg


View original content:https://www.prnewswire.com/news-releases/breast-reconstruction-market-size-to-reach-usd-826-2-million-in-2030--emergen-research-301737458.html

SOURCE Emergen Research